External whistleblowing policy

Human medicines European public assessment report (EPAR): Byetta, exenatide, Date of authorisation: 20/11/2006, Revision: 30, Status: Withdrawn

Policy 72: Policy on the handling of information from external persons on breaches related to the authorisation, supervision and maintenance of human and veterinary medicinal products or other EMA activities

Human medicines European public assessment report (EPAR): Bydureon, exenatide, Date of authorisation: 17/06/2011, Revision: 27, Status: Withdrawn

Human medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation: 01/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Sibnayal, potassium citrate,potassium hydrogen carbonate, Date of authorisation: 30/04/2021, Revision: 6, Status: Authorised

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 15 July 2026, 09:30 (CEST) to 15 July 2026, 13:30 (CEST)

Meeting summary - Medicine shortages SPOC working party meeting 15 July 2026

Human medicines European public assessment report (EPAR): Degevma, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised